(Press-News.org) January 11, 2011 – (BRONX, NY) – Intrauterine devices (IUDs) for contraception are safe and effective, but only a small fraction of women in the United States use them.
Now, a national survey of family physicians conducted by researchers at Albert Einstein College of Medicine of Yeshiva University, has found that family physicians typically have gaps in knowledge about IUDs, are often uncomfortable discussing them with patients, and frequently believe that their patients would not be receptive to talking about IUDs. The findings are published in the December 3 online issue of Contraception.
IUDs have a notable advantage over some other, more commonly used contraceptives. They are user-independent – meaning once inserted, they don't require action by the user to be effective. By removing the chance for human error (for example, forgetting to take a birth control pill or incorrectly using a barrier method), IUDs are often more effective in real-world conditions than more popular alternatives.
"IUDs only account for 5 percent of contraception used by women in the U.S., compared with approximately 15 percent worldwide," noted Susan Rubin, M.D., assistant professor of family and social medicine at Einstein and the paper's lead author. "While we acknowledge that a number of factors contribute to the low utilization of IUDs in the U.S., our study set out to determine what factors differentiate those family physicians who insert IUDs in their clinical practice versus those who don't." Family medicine is important to the issue since about one in four U.S. women seeking private family planning care turn to a family physician. Additionally, another national survey of family physicians reported that 99 percent dispense, prescribe or recommend oral contraceptives – but only 39 percent do so with IUDs.
The researchers sent surveys to 3,500 family physicians and received 973 back, of which 869 were validly completed and used for analysis. They categorized the physicians into "inserters" (those who had inserted an IUD in the past 12 months), and "non-inserters" (those who had not). Only 24 percent of responders were categorized as "inserters."
Both inserters and non-inserters were found to have a positive attitude toward IUD safety and efficacy. However, 96 percent of inserters said they felt comfortable discussing IUD use with their patients compared with 79 percent of non-inserters. In addition, 89 percent of inserters believed their patients are receptive to discussing IUDs compared with only 55 percent of non-inserters – a nearly 35 percent difference. Inserters were also more knowledgeable about the devices, correctly answering four questions about IUDs more frequently than non-inserters.
Finally, inserters were found to have performed significantly more IUD insertions during their residencies than did non-inserters. "If educational practices are changed to increase the frequency of insertions learned during residency, this could increase the proportion of family physicians in practice who actually offer IUDs for their patients, thus potentially increasing the use of this effective contraceptive method," said Dr. Rubin.
INFORMATION:
The study, "Determinants of intrauterine contraception provision among US family physicians: a national survey of knowledge, attitudes and practice," was published in the December 3 online edition of Contraception.Other Einstein authors, all in the department of family and social medicine, are Jason Fletcher, Ph.D., M.S., assistant professor; Tara Stein, M.D., M.P.H., assistant professor; and senior author Marji Gold, M.D., professor. Penina Segall-Gutierrez, M.D., M.S., at University of Southern California, Los Angeles, was also an author.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2009-2010 academic year, Einstein is home to 722 M.D. students, 243 Ph.D. students, 128 students in the combined M.D./Ph.D. program, and approximately 350 postdoctoral research fellows. The College of Medicine has 2,775 fulltime faculty members located on the main campus and at its clinical affiliates. In 2009, Einstein received more than $155 million in support from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive affiliation network involving five medical centers in the Bronx, Manhattan and Long Island - which includes Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein - the College of Medicine runs one of the largest post-graduate medical training programs in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training. For more information, please visit www.einstein.yu.edu
January 11, 2011 — (BRONX, NY) — A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization (IVF) will lead to a successful pregnancy. The test, reported in the online medical journal PLoS One, is based on the finding that different subtypes of the FMR1 gene (also known as the fragile X mental retardation gene) in potential mothers are associated with significantly different chances of conceiving with IVF.
"This is the first evidence that a specific ...
COLLEGE STATION, Jan. 11, 2011 – Biologists at Texas A&M University have made an important step toward understanding human mating behavior by showing that certain genes become activated in fruit flies when they interact with the opposite sex.
Their research, published in the January 2011 issue of the journal GENETICS, shows that courtship behaviors may be far more influenced by genetics than previously thought. In addition, this new understanding as to why and how these genes become activated within social contexts may also lead to insight into disorders such as autism.
"Be ...
GALVESTON, Texas — When most people in the developed world think of measles, what comes to mind is only a dim memory of a vaccination at a pediatrician's office. But while childhood vaccination has virtually eliminated measles from North America and much of Europe, researchers remain interested in the virus.
This fascination persists partly because improving the measles vaccine could help eliminate the more than 10 million measles infections and 150,000 measles-caused deaths that still occur worldwide. But it also has another source: Scientists believe that modified ...
Some disorders of the brain are obvious — the massive death of brain cells after a stroke, the explosion in the growth of cells that marks a tumor. Other disorders, such as autism, schizophrenia and mental retardation show no physical signs of damage and are believed to be caused by problems in how brain cells communicate with one another.
To understand the root of the problem of these latter diseases, visualizing brain activity is key. But even the best imaging devices available — fMRIs and PET scans — can only give a "coarse" picture of brain activity.
UCLA neuroscientists ...
Morgantown, WV, January 11, 2011 – A Blanchette Rockefeller Neurosciences Institute (BRNI) study published today in the Journal of Neuroscience reveals underlying causes for the degeneration of synapses in Alzheimer's Disease and identifies promising pharmaceutical solutions for the devastating condition that affects more than 5 million people in the United States. The BRNI study is the first to achieve fundamental molecular understanding of how synapses are lost in Alzheimer's Disease before the plaques and tangles develop. At the same time, it is the first study to ...
The estimated total cost of cancer care in the United States in 2020 is expected to be $158 billion assuming the most recent observed patterns of incidence, survival, and cost remain the same. This represents a 27% increase from 2010 due only to the projected aging and growth of the US population, according to a study published online January 12th in The Journal of the National Cancer Institute. However, the authors also note the cost of cancer care could rise even more quickly under some reasonable assumptions such as a 2% annual increase in costs of the initial and final ...
Washington, DC – Tinnitus appears to be produced by an unfortunate confluence of structural and functional changes in the brain, say neuroscientists at Georgetown University Medical Center (GUMC).
The phantom ringing sounds heard by about 40 million people in the U.S. today are caused by brains that try, but fail to protect their human hosts against overwhelming auditory stimuli, the researchers say in the January 13th issue of Neuron. They add that the same process may be responsible for chronic pain and other perceptual disorders.
The researchers say that the absence ...
Based on growth and aging of the U.S. population, medical expenditures for cancer in the year 2020 are projected to reach at least $158 billion (in 2010 dollars) – an increase of 27 percent over 2010, according to a National Institutes of Health analysis. If newly developed tools for cancer diagnosis, treatment, and follow-up continue to be more expensive, medical expenditures for cancer could reach as high as $207 billion, said the researchers from the National Cancer Institute (NCI), part of the NIH. The analysis appears online, Jan. 12, 2011, in the Journal of the National ...
(PHILADELPHIA) –The discovery that high levels of high-density lipoprotein (HDL) cholesterol (the "good cholesterol") is associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain. However, recent findings have called into question the notion that pharmacologic increases in HDL cholesterol levels are necessarily beneficial to patients. Now, a new study from researchers at the University of Pennsylvania School of Medicine shows that a different metric, a measure of HDL function called cholesterol efflux ...
A new study identifies a molecule that is a critical regulator of neuron survival after ischemic brain injury. The research, published by Cell Press in the January 13 issue of the journal Neuron, may lead to new therapies that reduce damage after a stroke or other injuries that involve an interruption in blood supply to the brain.
Ischemic brain injury is damage caused by a restriction in blood supply. Neuronal death after an interruption in the supply of oxygen and glucose involves a complex cascade of pathological events and, although previous research has identified ...
